UNAIDS and the Stop TB Partnership joined together on Thursday at the International AIDS Conference-AIDS 2010 in Vienna, Austria, with the goal of preventing 200,000 deaths annually from HIV and tuberculosis co-infection, Agence France-Presse reports. TB is the number one killer of people living with HIV/AIDS (Ingham, 7/22).
Global Health Conferences and Meetings
Managing editor of the Kaiser Daily Global Health Policy Report, Jill Braden Balderas, interviews global health leaders participating in AIDS 2010. brightcove.createExperiences(); Suniti Solomon, MD, director of the Y.R. Gaitonde Center for AIDS Research and Education (YRG CARE) in Chennai, India, explains how integration of care helps fight stigma and…
Managing editor of the Kaiser Daily Global Health Policy Report, Jill Braden Balderas, interviews global health leaders participating in AIDS 2010. brightcove.createExperiences(); Chris Collins, MPP, vice president and director of public policy at amfAR – the Foundation for AIDS Research, discusses U.S. funding for PEPFAR and research and how HIV…
Thousands of HIV/AIDS advocates “marched through Vienna’s city centre on Tuesday evening, demanding more respect for human rights in the fight against HIV,” Agence France-Presse reports.
The following webcasts are now available at http://globalhealth.kff.org/AIDS2010. WednesdayÂ – http://globalhealth.kff.org/AIDS2010.aspx#July21 Wednesday Plenary TB and HIV Management in High Prevalence Settings: From Coordination to Integration When Does HIV Funding Strengthen Health Systems? Providing Leadership on Critical HIV/AIDS Issues: An Appeal by and to Members of Parliament Funding Global Health: Can Innovative…
AIDS 2010 Studies, Releases: PMTCT, Treating Children, Male Circumcision; National Prevention Programs; IDUs
“In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine,” according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
RECENT RELEASE: CSIS Blog Posts Highlight Panel Discussions On PEPFAR, Examine Challenges To Administering Treatment-As-Prevention
“In advance of the XIX International AIDS Conference — AIDS 2012 — CSIS celebrated the release of the special supplement of the Journal of AIDS focused on PEPFAR” with an event organized in cooperation with the Office of the Global AIDS Coordinator (OGAC),” the Center for Strategic & International Studies’ (CSIS) “Smart Global Health” blog reports. According to the blog, the event “featured contributing authors and guest editors who are leading figures in PEPFAR and the international HIV/AIDS community” participating “in wide-ranging discussions of the successes and challenges of PEPFAR, from its inception to its future” (Fisher/Kramer, 7/23). In a related post in the blog, Phillip Nieburg, a senior associate at the CSIS Global Health Policy Center, examines the challenges of adopting treatment-as-prevention as a strategy to achieve an “AIDS-free generation” (7/23).
Susan Blumenthal, public health editor at Huffington Post and former U.S. assistant surgeon general, and Michelle Moses-Eisenstein, an Allan Rosenfield Health Policy Fellow with amfAR, the Foundation for AIDS Research in Washington, write in the Huffington Post Blog that the International AIDS Conference, held in Washinton this week, “will highlight opportunities for achieving an AIDS-free generation.” They add, “Of great concern right now is that the remarkable progress toward ending AIDS that has been made over the past decades is being threatened by a decline in resources and the threat of budget cuts to support HIV research and services worldwide.” They conclude, “If we are going to eradicate AIDS in America and worldwide, then a global strategic plan for achieving an HIV-free generation is needed that mobilizes all sectors of society across countries, scales up interventions that work to reach more people, makes programs more efficient and accountable, and invests in research to accelerate progress in ending HIV/AIDS, including intensifying efforts to discover both a cure and a vaccine” (7/23).
Bill Gates Stresses Importance Of Investment In Both HIV Treatment And Research For Vaccines, Microbicides
In a symposium session on Monday at the XIX International AIDS Conference in Washington, D.C., politicians and public health experts joined Bill & Melinda Gates Foundation Co-Chair Bill Gates for a discussion about improving effectiveness and efficiency in the HIV/AIDS response, the Washington Post reports (Brown/Botelho, 7/23). “Gates … reiterated the importance for nations and donors to support research, but also expressed support for ongoing treatment initiatives in the meantime,” according to Agence France-Presse. “No one should think that we have got the tools yet. We will get the tools but only if we stay the course in terms of the scientific investments,” Gates said, AFP notes (Sheridan, 7/23). The Washington Post adds that “[t]he main one lacking is a vaccine, but also important and missing are woman-controlled means to prevent infection, such as a vaginal microbicide” (7/23).
GlobalPost correspondent John Donnelly interviews Vanessa Kerry, daughter of Sen. John Kerry (D-Mass.) and a doctor working at Massachusetts General Hospital, about the partnership she spearheaded between her non-profit, the Global Health Service Corps, and the Peace Corps, in this post in the “Global Pulse” blog. According to the blog, “Kerry talked to GlobalPost about the partnership, her reasons for working with the Peace Corps on the project and her parents’ influence on her” (7/23).